Ovarian Germ Cell Cancer

Malignancies that arise from GERM CELLS of the embryonic gonad. They are relatively rare, accounting for less than 5% of ovarian cancers, and may be hereditary. OMIM: 603737

Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

Disease Context: Research Results

Related Diseases

1.	Ototoxicity

Experts

1.	Attademo, Laura: 1 article (10/2019)
2.	Bergamini, Alice: 1 article (10/2019)
3.	Casadei, Chiara: 1 article (10/2019)
4.	Cormio, Gennaro: 1 article (10/2019)
5.	De Giorgi, Ugo: 1 article (10/2019)
6.	Lorusso, Domenica: 1 article (10/2019)
7.	Mangili, Giorgia: 1 article (10/2019)
8.	Pignata, Sandro: 1 article (10/2019)
9.	Bunne, Marie: 1 article (01/2017)
10.	Fosså, Sophie D: 1 article (01/2017)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Ovarian Germ Cell Cancer:

1.	Cisplatin (Platino)FDA LinkGeneric 11/01/2000 - "The aim of the study was to evaluate some clinicopathologic characteristics and the outcome of patients with ovarian germ cell cancer (OGCC) treated with cisplatin-based chemotherapy. " 10/17/2019 - "The majority of patients with advanced ovarian germ cell cancer are treated by cisplatin-based chemotherapy. " 01/01/2017 - "Long-term ototoxicity in women after cisplatin treatment for ovarian germ cell cancer."
2.	PlatinumIBA 07/01/1996 - "Activity of gemcitabine in platinum-resistant ovarian germ cell cancer."
3.	GemcitabineFDA Link 07/01/1996 - "Activity of gemcitabine in platinum-resistant ovarian germ cell cancer."

Therapies and Procedures

1.	Drug Therapy (Chemotherapy) 11/01/2000 - "The aim of the study was to evaluate some clinicopathologic characteristics and the outcome of patients with ovarian germ cell cancer (OGCC) treated with cisplatin-based chemotherapy. " 10/17/2019 - "The majority of patients with advanced ovarian germ cell cancer are treated by cisplatin-based chemotherapy. "